Clinical trial
Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis…
NCT00043732 · Scios, Inc., Industry · Completed
Key facts
| NCT number | NCT00043732 |
|---|---|
| Title | Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate |
| Official title | A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study of SCIO-469 in Patients in Active Rheumatoid Arthritis Receiving Methotrexate |
| Lead sponsor | Scios, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | SCIO-469 |
| Enrollment | 120 |
| Completion | Sep 1, 2003 |
| First posted | Aug 14, 2002 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: